statistiche ricercatore

Continente	#
NA - Nord America	1.376
EU - Europa	737
AS - Asia	720
SA - Sud America	96
AF - Africa	29
OC - Oceania	3
Continente sconosciuto - Info sul continente non disponibili	2
Totale	2.963

Nazione	#
US - Stati Uniti d'America	1.344
IT - Italia	246
SG - Singapore	227
VN - Vietnam	164
CN - Cina	131
DE - Germania	113
RU - Federazione Russa	105
HK - Hong Kong	84
BR - Brasile	80
GB - Regno Unito	54
IN - India	52
SE - Svezia	44
IE - Irlanda	35
FR - Francia	26
CA - Canada	21
FI - Finlandia	20
ES - Italia	13
DK - Danimarca	12
NL - Olanda	12
UA - Ucraina	12
ET - Etiopia	10
ID - Indonesia	10
PL - Polonia	9
RO - Romania	9
TR - Turchia	8
MX - Messico	7
AT - Austria	6
EG - Egitto	6
KR - Corea	6
ZA - Sudafrica	6
AR - Argentina	5
IR - Iran	5
JP - Giappone	5
GE - Georgia	4
IQ - Iraq	4
VE - Venezuela	4
AU - Australia	3
BA - Bosnia-Erzegovina	3
BE - Belgio	3
CO - Colombia	3
MY - Malesia	3
NG - Nigeria	3
TH - Thailandia	3
AE - Emirati Arabi Uniti	2
AL - Albania	2
BD - Bangladesh	2
BG - Bulgaria	2
CH - Svizzera	2
DZ - Algeria	2
EC - Ecuador	2
JO - Giordania	2
LT - Lituania	2
MD - Moldavia	2
PK - Pakistan	2
RS - Serbia	2
UZ - Uzbekistan	2
CI - Costa d'Avorio	1
CL - Cile	1
DO - Repubblica Dominicana	1
EU - Europa	1
HU - Ungheria	1
JM - Giamaica	1
KE - Kenya	1
KG - Kirghizistan	1
NI - Nicaragua	1
NP - Nepal	1
PA - Panama	1
PH - Filippine	1
PT - Portogallo	1
PY - Paraguay	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	2.963

Nome	#
Two novel SCN5A loss-of-function mutations affect patients with severe arrhytmogenic syndromes	397
Effect of the ketogenic diet in excitable tissues	385
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease	379
Progressive epileptic encephalopathy associated with a novel HCN2 mutation	330
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy	329
Channelopathies and epileptic syndromes: characterization of novel variants associated with progressive epileptic encephalopathy and in vitro validation of therapeutic approaches	320
Caveolin-3 and Caveolin-1 Interaction Decreases Channel Dysfunction Due to Caveolin-3 Mutations	275
Innovative therapies and nanomedicine applications for the treatment of alzheimer’s disease: A state-of-the-art (2017–2020)	267
HCN1 novel mutations in familiar generalized epilepsy	232
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet	204
Totale	3.118

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	257	0	0	0	0	0	0	49	59	38	36	34	41
2021/2022	197	33	38	30	21	6	9	11	12	5	7	4	21
2022/2023	249	22	80	29	19	21	36	4	9	18	3	4	4
2023/2024	270	4	11	8	27	46	55	18	23	25	12	5	36
2024/2025	567	34	60	39	24	52	29	29	30	57	91	48	74
2025/2026	995	244	65	98	221	188	88	91	0	0	0	0	0
Totale													3.118

Bicocca Open Archive